(Q44190664)

English

Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis

scientific article published on 14 January 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

0 references

Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

0 references

0 references

multiple myeloma

1 reference

based on heuristic

inferred from title

corrigendum / erratum

Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis

0 references

Angela Dispenzieri

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

9

object named as

R A Kyle

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

S. Vincent Rajkumar

2

object named as

S V Rajkumar

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

4

object named as

M A Gertz

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

5

object named as

M Q Lacy

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

6

object named as

D Dingli

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

P Kapoor

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

J R Mikhael

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

V Roy

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

P R Greipp

10

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

S Kumar

11

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

S J Mandrekar

12

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

14 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

689-696

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Autologous stem cell transplantation in the elderly including pre- and post-treatment options

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Autologous hematopoietic stem-cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Response rate and survival in myeloma patients receiving prednisone alone.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Thalidomide and dexamethasone combination for refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

21 January 2018

Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance therapy with thalidomide improves survival in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.313

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2010.313

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44190664&oldid=2206487104"